Search research articles
Contact Us
Filters
Showing results (71-80 of 124) with videos related to
Page
of 13
Sort By:
The Journal of Dermatological Treatment
|
April 18, 2024
Efficacy of risankizumab across subgroups in patients with active psoriatic arthritis: a post hoc integrated analysis of the phase 3 KEEPsAKE 1 and KEEPsAKE 2 randomized controlled trials
Joseph F Merola, April Armstrong, Saakshi Khattri, et al.
Journal of the American Academy of Dermatology
|
December 5, 2025
Differences in Prescription Patterns Among Various Physician Specialties for Patients with Chronic Spontaneous Urticaria
Peichi Chou, Elaine Ma, Alyssa Roberts, et al.
Journal of Drugs in Dermatology : JDD
|
December 1, 2018
Adverse Medical Conditions Across Treatment Options in Patients With Psoriasis: A Claims-Based Analysis
Jashin Wu, April Armstrong, Rakesh Singh, et al.
Dermatology and Therapy
|
September 27, 2023
Skin Clearance is Associated with Reduced Treatment Failure in Patients with Psoriasis: Real-World Evidence from the CorEvitas Psoriasis Registry
Robert R McLean, Adam P Sima, Silky Beaty, et al.
Dermatology and Therapy
|
April 22, 2024
Sustained Improvements in Clinical and Patient-Reported Outcomes and Quality of Life Through 5 Years Among Ixekizumab-Treated Patients with Complete Clearance of Scalp Psoriasis by Week 60
Alexander Egeberg, Jason E Hawkes, Najwa Somani, et al.
Journal of the American Academy of Dermatology
|
September 22, 2023
Real-world effectiveness of risankizumab in patients with moderate-to-severe psoriasis using the CorEvitas Psoriasis Registry
Bruce Strober, Laura Ferris, Kristina Callis Duffin, et al.
Dermatology and Therapy
|
November 15, 2025
Matching-Adjusted Indirect Comparison of the Efficacy of Delgocitinib Cream and Dupilumab in the Treatment of Moderate to Severe Atopic Hand Eczema
David Cohen, Anthony Bewley, Andreas Wollenberg, et al.
JAAD International
|
November 17, 2025
Supporting evidence and recommendations for the management of patients with systemic-eligible atopic dermatitis: A Canadian consensus document
Kerri Purdy, Melinda Gooderham, Mohannad Abu-Hilal, et al.
Dermatology and Therapy
|
March 24, 2024
Comparing Achievement of National Psoriasis Foundation Treatment Targets among Patients with Plaque Psoriasis Treated with Ixekizumab versus Other Biologics in Clinical and Real-World Studies
April Armstrong, Alvaro González-Cantero, Saakshi Khattri, et al.
Dermatology and Therapy
|
September 27, 2023
Durability of Near-Complete Skin Clearance in Patients with Psoriasis Using Systemic Biologic Therapies: Real-World Evidence from the CorEvitas Psoriasis Registry
Robert R McLean, Adam P Sima, Silky Beaty, et al.
Page
of 13
Search research articles
Search
Showing results (71-80 of 124) with videos related to
Sort By:
Page
of 13
The Journal of Dermatological Treatment
|
April 18, 2024
Efficacy of risankizumab across subgroups in patients with active psoriatic arthritis: a post hoc integrated analysis of the phase 3 KEEPsAKE 1 and KEEPsAKE 2 randomized controlled trials
Joseph F Merola, April Armstrong, Saakshi Khattri, et al.
Journal of the American Academy of Dermatology
|
December 5, 2025
Differences in Prescription Patterns Among Various Physician Specialties for Patients with Chronic Spontaneous Urticaria
Peichi Chou, Elaine Ma, Alyssa Roberts, et al.
Journal of Drugs in Dermatology : JDD
|
December 1, 2018
Adverse Medical Conditions Across Treatment Options in Patients With Psoriasis: A Claims-Based Analysis
Jashin Wu, April Armstrong, Rakesh Singh, et al.
Dermatology and Therapy
|
September 27, 2023
Skin Clearance is Associated with Reduced Treatment Failure in Patients with Psoriasis: Real-World Evidence from the CorEvitas Psoriasis Registry
Robert R McLean, Adam P Sima, Silky Beaty, et al.
Dermatology and Therapy
|
April 22, 2024
Sustained Improvements in Clinical and Patient-Reported Outcomes and Quality of Life Through 5 Years Among Ixekizumab-Treated Patients with Complete Clearance of Scalp Psoriasis by Week 60
Alexander Egeberg, Jason E Hawkes, Najwa Somani, et al.
Journal of the American Academy of Dermatology
|
September 22, 2023
Real-world effectiveness of risankizumab in patients with moderate-to-severe psoriasis using the CorEvitas Psoriasis Registry
Bruce Strober, Laura Ferris, Kristina Callis Duffin, et al.
Dermatology and Therapy
|
November 15, 2025
Matching-Adjusted Indirect Comparison of the Efficacy of Delgocitinib Cream and Dupilumab in the Treatment of Moderate to Severe Atopic Hand Eczema
David Cohen, Anthony Bewley, Andreas Wollenberg, et al.
JAAD International
|
November 17, 2025
Supporting evidence and recommendations for the management of patients with systemic-eligible atopic dermatitis: A Canadian consensus document
Kerri Purdy, Melinda Gooderham, Mohannad Abu-Hilal, et al.
Dermatology and Therapy
|
March 24, 2024
Comparing Achievement of National Psoriasis Foundation Treatment Targets among Patients with Plaque Psoriasis Treated with Ixekizumab versus Other Biologics in Clinical and Real-World Studies
April Armstrong, Alvaro González-Cantero, Saakshi Khattri, et al.
Dermatology and Therapy
|
September 27, 2023
Durability of Near-Complete Skin Clearance in Patients with Psoriasis Using Systemic Biologic Therapies: Real-World Evidence from the CorEvitas Psoriasis Registry
Robert R McLean, Adam P Sima, Silky Beaty, et al.
Page
of 13